Organization and Basis of Presentation (Details Narrative) - USD ($)	1 Months Ended	12 Months Ended
	Aug. 17, 2021	Dec. 31, 2022	Dec. 31, 2021
Accumulated deficit		$ (45,600,000)
Cash and cash equivalents		6,200,000
Common Stock Exercise Price	$ 7
Net Cash Used In Operation		$ 8,800,000	$ 5,700,000
Sale of stock	2,571,428
Warrants to purchase one share of common stock	2,957,142
Conversion of stock	65,823,015
Warrant exercise price		$ 7
Common stock outstanding		12,321,848	8,328,629
Conversion of stock amount		$ 0	$ 6,582
Convertible Notes [Member]
Conversion of stock	32,219
Accrued interest	$ 5,434
Conversion of stock amount	$ 175,000
Initial Public Offering [Member]
Sale of stock	2,571,428
Warrants to purchase one share of common stock	2,571,428
Warrant exercise price	$ 7
Combined Offering Price	$ 7
Common stock outstanding	1,911,009
Incremental number of warrants issued at IPO	385,714
Option exercise price	$ 7
Gross Proceeds from warrants purchase of common stock	$ 15,400,000
Issuance costs	$ 2,600,000
Common Stock [Member]
Conversion of stock	3,813,973
Series 1a Preferred Stock
Conversion of stock	1,419,228
Warrants exercisable into common stock	69,212